InvestorsHub Logo
Followers 21
Posts 1400
Boards Moderated 0
Alias Born 03/03/2021

Re: biosectinvestor post# 506507

Friday, 08/19/2022 5:11:45 PM

Friday, August 19, 2022 5:11:45 PM

Post# of 692862
Bio, I think the revenue protection would be gained from Dr.'s and Patients choosing the less intrusive and probably less expensive jab. The GBM market for Keytruda is probably a niche market as far as they would see numbers.

Can we see a Keytruda/DCVAX combo injection? ... LOL.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News